Skip to main content
Premium Trial:

Request an Annual Quote

HemoGenix to Help ImmuneRegen Validate Bioterror Drug Candidate

NEW YORK (GenomeWeb News) – The stem cell-based pharmaceutical company ImmuneRegen will use HemoGenix’ cell-based assay technology in its studies of a therapeutic candidate designed as a response to bioterrorism threats, ImmuneRegen said today.
The agreement calls for HemoGenix to use its instrument-based ATP bioluminescence technology to study the ability of a drug called Homspera to stimulate hematopoietic stem cell proliferation. The drug is derived from Substance P, a naturally occurring peptide immunomodulator and homeostatic compound that can improve pulmonary function and stimulate the human immune system, ImmuneRegen said.
HemoGenix’s technology offers a method for standardizing and validating the stem cell colony-forming cell differentiation assay, according to ImmuneRegen.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.